The future of immunotherapy: A growing market and a revolutionary approach
24 Feb 2025 - Immuno-oncology’s Expanding Role in Cancer Treatment
24 Feb 2025 - Immuno-oncology’s Expanding Role in Cancer Treatment
07 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.
05 Feb 2025 - CEO Andrew Terry discusses long-range wi-fi, semiconductor challenges, and the future of IoT connectivity.
03 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.
16 Jan 2025 - Off the Chain Capital's CIO Brian Estes discusses Bitcoin's ethical implications, investment metrics, and future outlook.
13 Dec 2024 - Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.
11 Dec 2024 - INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
07 Dec 2024 - Mount Hope Mining is preparing for a 9 December ASX listing, focusing on copper and gold exploration in the Cobar Basin, with five high-priority targets and a strategy based on recent geological insights.
26 Nov 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
18 Nov 2024 - Empire Energy Group Limited (ASX:EEG) has commenced drilling for its Carpentaria Pilot Project after receiving environmental clearance. The initiative aims to deliver much-needed gas to the Northern Territory and east coast markets, supported by local and federal government strategies.